Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Alamar Biosciences, Inc.NASDAQ: ALMR

Operating Expenses · Q2 FY2026 · quarter ended Jun 2026

Operating expenses of $31.25M in Q2 FY2026

Q2 FY2026 operating expenses was $31.25M.

Context

  • Operating expenses amounted to 98.4% of revenue in FY2025.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$31.25M+16.6% QoQ
Last fiscal yearDec 2025
$73.04M— YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
73.04M USD
Year-over-year change
—

Operating Expenses vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 operating expenses of $73.04M is the 8th highest of the 9 companies compared; the peer median is $171.14M.
  • Operating expenses amounts to 98.4% of revenue for ALMR, versus a peer median of 138.8%.
ALMR Competitors Peer median
Operating Expenses for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TECHBio-Techne CorporationLTM Sep 2026$566.75M -17.3%+5.1%46.1%
TXG10x Genomics, Inc.LTM Sep 2026$516.85M -3.0%-0.5%83.6%
TWSTTwist Bioscience CorporationLTM Sep 2026$380.26M +16.2%+7.4%82.8%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$222.12M -73.8%+19.5%138.8%
LABStandard BioTools Inc.LTM Mar 2026$120.17M -35.3%-3.9%139.3%
QSIQuantum-Si incorporatedLTM Mar 2026$97.04M -13.5%-7.3%5239.8%
SEERSeer, Inc.LTM Mar 2026$81.9M -18.3%-6.5%544.6%
ALMRAlamar Biosciences, Inc.FY2025$73.04M ——98.4%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$61.05M -11.7%+0.1%—
Peer median (excluding ALMR) $171.14M-15.4%-0.2%138.8%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.